The Helicobacter felis model of adoptive transfer gastritis

Immunologic Research

Volumn 33, Issue 2, 2005, Pages 183-194

  McCracken, Vance J ^a   Martin, Steven M ^b   Lorenz, Robin G ^a,c,d  

^a University of Alabama at Birmingham   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Adoptive transfer; Animal model; Gastritis; Helicobacter; T cell

Indexed keywords

CD4 ANTIGEN;

ADOPTIVE TRANSFER; BIOLOGICAL MODEL; CELL INFILTRATION; CELLULAR IMMUNITY; DUODENUM ULCER; EPITHELIUM; GASTRITIS; HELICOBACTER FELIS; HELICOBACTER INFECTION; IMMUNE RESPONSE; LYMPHOCYTIC INFILTRATION; MONOCYTE; NATURAL KILLER CELL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOLOGY; PLASMA CELL; PRIORITY JOURNAL; REVIEW; STOMACH ADENOCARCINOMA; STOMACH ULCER; T LYMPHOCYTE;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; DISEASE MODELS, ANIMAL; GASTRITIS; HELICOBACTER FELIS; HUMANS; MODELS, IMMUNOLOGICAL;

EID: 26844501817     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:33:2:183     Document Type: Review

References (62)

1. Marshall BJ, Goodwin CS, Warren JR, et al.: Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;2:1437-1442.
2. Marshall BJ, Warren JR: Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1984;1:1273-1275.
3. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA: The cohort effect and Helicobacter pylori. J Infect Dis 1993;168:219-221.
4. Telford JL, Covacci A, Rappuoli R, Chiara P: Immunobiology of Helicobacter pylori infection. Curr Opin Immunol 1997;9:498-503.
5. Peek RM Jr, Blaser MJ: Pathophysiology of Helicobacter pylori-induced gastritis and peptic ulcer disease. Am J Med 1997;102:200-207.
6. Rowland M, Imrie C, Bourke B, Drumm B: How should Helicobacter pylori infected children be managed? Gut 1999;45(Suppl 1):I36-39.
7. Nardone G, Rocco A, Malfertheiner P: Review article: Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 2004;20:261-270.
8. Blaser MJ, Atherton JC: Helicobacter pylori persistence: biologyand disease. J Clin Invest 2004;113:321-333.
9. Metz DC: Helicobacter colonization of the biliary tree: commensal, pathogen, or spurious finding? Am J Gastroenterol 1998;93:1996-1998.
10. McCracken VJ, Lorenz RG: The gastrointestinal ecosystem: a precarious alliance among epithelium, immunity and microbiota. Cell Microbiol 2001;3:1-11.
11. Cover TL, Blanke SR: Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 2005;3:320-332.
12. Montecucco C, Rappuoli R: Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol 2001;2:457-466.
13. Baldari CT, Lanzavecchia A, Telford JL: Immune subversion by Helicobacter pylori. Trends Immunol 2005;26:199-207.
14. Rieder G, Fischer W, Haas R: Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules. Curr Opin Microbiol 2005;8:67-73.
15. Go MF, Crowe SE: Virulence and pathogenicity of Helicobacter pylori. Gastroenterol Clin North Am 2000;29:649-670.
16. Kersulyte D, Mukhopadhyay AK, Velapatino B, et al.: Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol 2000:182:3210-3218.
17. Falush D, Wirth T, Linz B, et al.: Traces of human migrations in Helicobacter pylori populations. Science 2003;299:1582-1585.
18. El-Omar EM: The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001;48:743-747.
19. Israel DA, Salama N, Krishna U, et al.: Helicobacter pylori genetic diversity within the gastric niche of a single human host. Proc Natl Acad Sci USA 2001;98:14625-14630.
20. Lee A, O'Rourke J, De Ungria MC, Robertson B, Daskalopoulos G, Dixon MF: A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 1997;112:1386-1397.
21. Eaton KA: Animal models of Helicobacter gastritis. Curr Top Microbiol Immunol 1999;241:123-154.
22. Blanchard TG, Czinn SJ, Nedrud JG, Redline RW: Helicobacter-associated gastritis in SCID mice. Infect Immun 1995;63:1113-1115.
23. Lee A, Fox JG, Otto G, Murphy J: A small animal model of human Helicobacter pylori active chronic gastritis. Gastroenterology 1990;99:1315-1323.
24. Mohammadi M, Redline R, Nedrud J, Czinn S: Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun 1996;64:238-245.
25. Sutton P, Wilson J, Genta R, et al.: A genetic basis for atrophy: dominant non-responsiveness and Helicobacter induced gastritis in F(1) hybrid mice. Gut 1999;45:335-340.
26. Ferrero RL, Ave P, Radcliff FJ, Labigne A, Huerre MR: Outbred mice with long-term Helicobacter felis infection develop both gastric lymphoid tissue and glandular hyperplastic lesions. J Pathol 2000;191:333-340.
27. Roth KA, Kapadia SB, Martin SM, Lorenz RG: Cellular immune responses are essential for the development of Helicobacter felis-associated gastric pathology. J Immunol 1999;163:1490-1497.
28. Sakagami T, Dixon M, O'Rourke J, et al.: Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut 1996;39:639-648.
29. Mohammadi M, Redline R, Nedrud J, Czinn S: Role of the host in pathogenesis of Helicobacter-associated gastritis: H. felis infection of inbred and congenic mouse strains. Infect Immun 1996;64:238-245.
30. Schreiber S, Konradt M, Groll C, et al.: The spatial orientation of Helicobacter pylori in the gastric mucus. Proc Natl Acad Sci USA 2004;101:5024-5029.
31. Xiang Z, Censini S, Bayeli PE, et al.: Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-98.
32. Fox JG, Blanco M, Murphy JC, et al.: Local and systemic immune responses in murine Helicobacter felis active chronic gastritis. Infect Immun 1993;61:2309-2315.
33. Syed SA, Abrams GD, Freter R: Efficiency of various intestinal bacteria in assuming normal functions of enteric flora after association with germ-free mice. Infect Immun 1970;2:376-386.
34. van Doorn NE, Namavar F, Sparrius M, et al.: Helicobacter pylori-associated gastritis in mice is host and strain specific. Infect Immun 1999;67:3040-3046.
35. Mahler M, Janke C, Wagner S, Hedrich HJ: Differential susceptibility of inbred mouse strains to Helicobacter pylori infection. Scand J Gastroenterol 2002;37:267-278.
36. Ismail HF, Fick P, Zhang J, Lynch RG, Berg DJ: Depletion of neutrophils in IL-10(-/-) mice delays clearance of gastric Helicobacter infection and decreases the Th1 immune response to Helicobacter. J Immunol 2003;170:3782-3789.
37. Eaton KA, Ringler SR, Danon SJ: Murine splenocytes induce severe gastritis and delayed-type hypersensitivity and suppress bacterial colonization in Helicobacter pylori-infected SCID mice. Infect Immun 1999;67:4594-4602.
38. Negrini R, Lisato L, Zanella I, et al.: Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991;101:437-445.
39. Claeys D, Faller G, Appelmelk BJ, Negrini R, Kirchner T: The gastric H+,K+-ATPase is a major autoantigen in chronic Helicobacter pylori gastritis with body mucosa atrophy. Gastroenterology 1998;115:340-347.
40. Corthesy-Theulaz I, Corthesy B, Bachmann D, Velin D, Kraehenbuhl JP: Passive immunity in Helicobacter-challenged neonatal mice conferred by immunized dams lasts until weaning. Infect Immun 2003:71:2226-2229.
41. Marnila P, Rokka S, Rehnberg-Laiho L, et al.: Prevention and suppression of Helicobacter felis infection in mice using colostral preparation with specific antibodies. Helicobacter 2003;8:192-201.
42. Blanchard TG, Czinn SJ, Redline RW, Sigmund N, Harriman G, Nedrud JG: Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice. Cell Immunol 1999;191:74-80.
43. Sutton P, Wilson J, Kosaka T, Wolowczuk I, Lee A: Therapeutic immunization against Helicobacter pylori infection in the absence of antibodies. Immunol Cell Biol 2000;78:28-30.
44. Gottwein JM, Blanchard TG, Targoni OS, et al.: Protective anti-Helicobacter immunity is induced with aluminum hydroxide or complete Freund's adjuvant by systemic immunization. J Infect Dis 2001;184:308-314.
45. Eaton KA, Mefford M, Thevenot T: The role of T cell subsets and cytokines in the pathogenesis of Helicobacter pylori gastritis in mice. J Immunol 2001;166:7456-7461.
46. Peterson RA 2nd, Hoepf T, Eaton KA: Adoptive transfer of splenocytes in SCID mice implicates CD4+ T cells in apoptosis and epithelial proliferation associated with Helicobacter pylori-induced gastritis. Comp Med 2003;53:498-509.
47. Lucas B, Bumann D, Walduck A, et al.: Adoptive transfer of CD4+ T cells specific for subunit A of Helicobacter pylori urease reduces H. pylori stomach colonization in mice in theabsence of interleukin-4 (IL-4)/IL-13 receptor signaling. Infect Immun 2001;69:1714-1721.
48. Martin SM, Mehta IK, Yokoyama WM, Thomas ML, Lorenz RG: Development of intestinal intraepithelial lymphocytes, NK cells, and NK 1.1+ T cells in CD45-deficient mice. J Immunol 2001;166:6066-6073.
49. Roth KA, Kapadia SB, Martin SM, Lorenz RG: Cellular immune responses are essential for the development of Helicobacter felis-associated gastric pathology. J Immunol 1999;163:1490-1497.
50. Nadler LM, Anderson KC, Marti G, et al.: B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 1983;131:244-250.
51. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM: CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulator cells. J Immunol 1998;160:1212-1218.
52. a donors. Diabetes 1993;42:44-55.
53. Haskins K, McDuffie M: Acceleration of diabetes in young NOD mice with a CD4+ islet-specific T cell clone. Science 1990;249:1433-1436.
54. Kim S, Iizuka K, Kang HS, et al.: In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002;3:523-528.
55. Lundgren A, Suri-Payer E, Enarsson K, Svennerholm AM, Lundin BS: Helicobacter pylori-specific CD4+ CD25high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect Immun 2003;71:1755-1762.
56. Lundgren A, Stromberg E, Sjoling A, et al.: Mucosal FOXP3-expressing CD4+ CD25 high regulatory T cells in Helicobacter pylori-infected patients. Infect Immun 2005;73:523-531.
57. Raghavan S, Suri-Payer E, Holmgren J: Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells. Scand J Immunol 2004;60:82-88.
58. Raghavan S, Fredriksson M, Svennerholm AM, Holmgren J, Suri-Payer E: Absence of CD4+CD25+ regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin Exp Immunol 2003;132:393-400.
59. Eaton KA, Logan SM, Baker PE, Peterson RA, Monteiro MA, Altman E: Helicobacter pylori with a truncated lipopolysaccharide O chain fails to induce gastritis in SCID mice injected with splenocytes from wild-type C57BL/6J mice. Infect Immun 2004;72:3925-3931.
60. Ermak TH, Giannasca PJ, Nichols R, et al.: Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 1998;188:2277-2288.
61. Pappo J, Torrey D, Castriotta L, Savinainen A, Kabok Z, Ibraghimov A: Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun 1999;67:337-341.
62. Eaton KA, Mefford ME: Cure of Helicobacter pylori infection and resolution of gastritis by adoptive transfer of splenocytes in mice. Infect Immun 2001;69:1025-1031.